<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00960271</url>
  </required_header>
  <id_info>
    <org_study_id>2007/138/HP</org_study_id>
    <secondary_id>EVIEPEB</secondary_id>
    <nct_id>NCT00960271</nct_id>
  </id_info>
  <brief_title>Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)</brief_title>
  <acronym>EVIEPEB</acronym>
  <official_title>Medico-economic Evaluation of a Preoperative Algorithm Including EBUS for NSCLC Initial Staging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess both the role and cost-effectiveness of EBUS in preoperative Non
      small cell lung cancer staging. This controlled multicentric study will be conducted in 22
      centers in France. The study design includes two prospective phases. In phase 1, one
      investigator in each center will prospectively be evaluated for its ability to perform EBUS,
      with a required goal of 9 informative samplings out of 10 consecutive patients. The phase 2
      will include the medico-economic assessment of the technique in the preoperative setting. A
      maximum of 420 patients for each phase is forecasted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of mediastinoscopy avoided</measure>
    <time_frame>24h</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">363</enrollment>
  <condition>Non Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>NON SMALL CELL LUNG CANCER</arm_group_label>
    <description>Non small cell lung cancer, with clinical N2 disease, otherwise operable.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS</intervention_name>
    <description>a minimally invasive technique of mediastinal lymph node staging using an integrated videoendoscopic device equipped with ultrasound for the localization and transbronchial sampling of lymph nodes in real time</description>
    <arm_group_label>NON SMALL CELL LUNG CANCER</arm_group_label>
    <other_name>NSCLC</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include non small cell lung cancer patients, stage III A (before PET Scan),
        with resectable tumors.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients over 18

          -  non small cell lung cancer histologically or cytologically proved

          -  Clinical Stage IIIA

          -  anatomically and functionally resectable

        Exclusion Criteria:

          -  uncorrected bleeding disorders

          -  absence of lymphadenopathy superior to 1cm in small axis at CT scan

          -  contraindication to bronchoscopy

          -  extrathoracic or intrathoracic metastasis

          -  respiratory function tests not compatible with curative resection of lung cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2009</study_first_submitted>
  <study_first_submitted_qc>August 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2009</study_first_posted>
  <last_update_submitted>January 17, 2013</last_update_submitted>
  <last_update_submitted_qc>January 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-small cell lung cancer</keyword>
  <keyword>mediastinal lymph node</keyword>
  <keyword>resectable</keyword>
  <keyword>EBUS</keyword>
  <keyword>stage IIIA</keyword>
  <keyword>significant mediastinal lymph node at thoracic CT Scan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

